BJR
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

British Journal of Radiology (2003) 76, 662-665
© 2003 British Institute of Radiology
doi: 10.1259/bjr/85069069

This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Butteriss, D J A
Right arrow Articles by Birchall, D
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Butteriss, D J A
Right arrow Articles by Birchall, D

Case report

Use of serial proton magnetic resonance spectroscopy to differentiate low grade glioma from tumefactive plaque in a patient with multiple sclerosis

D J A Butteriss, MRCP 1 A Ismail, FRCPath 2 D W Ellison, FRCPath 2 and D Birchall, FRCR 1

Departments of 1 Neuroradiology and 2 Neuropathology, Newcastle General Hospital, Westgate Road, Newcastle upon Tyne NE4 6BE, UK

Correspondence: Dr D Birchall

We report on the use of serial proton MR spectroscopy (1H MRS) to differentiate between glioma and tumefactive plaque in a known multiple sclerosis (MS) patient who developed a symptomatic cerebral space occupying lesion. Gliomas and acute MS plaques may have indistinguishable chemical resonance spectra, whereas that of chronic plaque is distinct. In our case 1H MRS demonstrated elevated concentrations of choline, lactate and lipid, with reduced N-acetyl aspartate, a pattern consistent with either low grade glioma or acute demyelinating plaque. A repeat study 4 months later showed no change, this was felt to be incompatible with the natural history of an acute plaque and low grade glioma was diagnosed. Surgical removal of the lesion revealed an oligodendroglioma, confirming the imaging findings.




This article has been cited by other articles:


Home page
J Child NeurolHome page
J. Dastgir and F. J. DiMario Jr
Acute Tumefactive Demyelinating Lesions in a Pediatric Patient With Known Diagnosis of Multiple Sclerosis: Review of the Literature and Treatment Proposal
J Child Neurol, April 1, 2009; 24(4): 431 - 437.
[Abstract] [PDF]


Home page
BrainHome page
C. F. Lucchinetti, R. H. Gavrilova, I. Metz, J. E. Parisi, B. W. Scheithauer, S. Weigand, K. Thomsen, J. Mandrekar, A. Altintas, B. J. Erickson, et al.
Clinical and radiographic spectrum of pathologically confirmed tumefactive multiple sclerosis
Brain, July 1, 2008; 131(7): 1759 - 1775.
[Abstract] [Full Text] [PDF]


Home page
Mult SclerHome page
S. M Selkirk and J. Shi
Relapsing-remitting tumefactive multiple sclerosis
Multiple Sclerosis, December 1, 2005; 11(6): 731 - 734.
[Abstract] [PDF]


Home page
Mult SclerHome page
C. Enzinger, S. Strasser-Fuchs, S. Ropele, P. Kapeller, R. Kleinert, and F. Fazekas
Tumefactive demyelinating lesions: conventional and advanced magnetic resonance imaging
Multiple Sclerosis, April 1, 2005; 11(2): 135 - 139.
[Abstract] [PDF]


Home page
Br. J. Radiol.Home page
J H Jaster and T W Smith
Demyelination in the brain as a paraneoplastic disorder
Br. J. Radiol., October 1, 2004; 77(922): 899 - 899.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
BJR DMFR IMAGING  ALL BIR JOURNALS 
Copyright © 2003 by the British Institute of Radiology.